Have You Ever Seen An Onion Cry? - Page 2
The report argued that as Avastin is not marketed for eye treatment, pharmacists have to split vials of the drug into far smaller doses than when it is used to treat cancer.
In the U.S., the Department of Veterans Affairs last month stopped its use after reports of infections.
The report also alleged that some patients have lost their remaining sight after treatment and that one man is suing for £2.6million for loss of sight and brain damage as a result of an infection.
If like me and thousands of other patients, he was given written advice and asked to sign a consent form before treatment, I can’t believe he has a case.
That aside, the Mail article confirmed: “Roche, makers of Avastin, is not obliged to test its use in AMD, so publicly funded trials are under way. In April, a U.S. trial found the two drugs were equally effective in treating AMD after one year.”
The report added: “The rate of hospitalizations was 24 per cent for Avastin and 19 per cent for Lucentis. Some doctors attribute infections from Avastin to contamination by splitting vials into small doses.”
Writing from personal experience, I confirm I was treated with a combination, first of photodynamic therapy (‘PDT’) and then several Avastin injections and had a further shot after the initial course when the problem appeared to have recurred.
Although I experienced severe short-term pain after each injection, there was no infection and the macular has since been stable.
Ophthalmologists in Israel, where I now live, offer a '50/50' recommendation to both drugs. However I have developed a further problem with epiretinal membranes in both eyes which may have to be removed with a surgical technique called an ‘epiretinal membrane peel’. This is when you could see an onion cry!